We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ARVN market cap is 2B. The company's latest EPS is USD -5.3948 and P/E is -5.54.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 32.5M | 54.5M | 34.6M | -43.1M | 25.3M |
| Operating Income | -87.7M | -77M | -74M | -165.3M | -83.3M |
| Net Income | -81.9M | -66.6M | -64M | -154.8M | -69.4M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 42.98M | 21.8M | 46.7M | 131.4M | 78.5M |
| Operating Income | -76.2M | -124.86M | -195.3M | -273.8M | -404M |
| Net Income | -70.29M | -119.33M | -191M | -282.5M | -367.3M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.18B | 1.08B | 1.06B | 1.3B | 1.21B |
| Total Liabilities | 664.8M | 619.9M | 601.1M | 644.6M | 602.9M |
| Total Equity | 511M | 463.6M | 457.2M | 660M | 609.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 301.64M | 717.37M | 1.58B | 1.27B | 1.3B |
| Total Liabilities | 74.96M | 75.11M | 799.9M | 703.9M | 644.6M |
| Total Equity | 226.69M | 642.26M | 781.7M | 564.9M | 660M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -91.2M | -179.9M | -264.7M | -347.8M | -97.7M |
| Investing | 138.6M | 187.2M | 257.2M | 203.5M | -127.8M |
| Financing | 1.5M | 2M | 39.9M | 374.7M | 1.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -40.63M | -89.76M | 559.4M | -273.5M | -347.8M |
| Investing | -93.1M | 164.25M | -1.31B | 242.8M | 203.5M |
| Financing | 139.74M | 504.67M | 278.6M | 4.7M | 374.7M |
| Market Cap | 2B |
| Price to Earnings Ratio | -5.54 |
| Price to Sales Ratio | 25.91 |
| Price to Cash Ratio | 6.52 |
| Price to Book Ratio | 3.08 |
| Dividend Yield | - |
| Shares Outstanding | 68.08M |
| Average Volume (1 week) | 974.58k |
| Average Volume (1 Month) | 788.52k |
| 52 Week Change | 26.97% |
| 52 Week High | 53.08 |
| 52 Week Low | 13.57 |
| Spread (Intraday) | 0.12 (0.41%) |
| Company Name | Arvinas Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.arvinas.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
